Home About Us Overview Robust R & D
   

Robust R & D

One of the largest R&D facilities in India, Aurobindo Pharma has three research centres spread over 16000 square meters. The company employs over 650 scientists (including 35 PhDs). In-house expertise in product development ensures a quick turnaround time in areas such as:

  • Project / product identification
  • Literature evaluation / patent study
  • API process development
  • Formulation development
  • Pilot BA / BE
  • Exhibiting batches for dossier submission
  • Stability studies for global requirements
  • Dossier submission

Aurobindo is also associated with UNO for development of ARVs (Pediatric and fixed dose combinations). Apart from NDA filings, the company contributes to over 2300 dossier filings worldwide. It has established capabilities in Contract Research and Manufacturing Services (CRAMS) and regularly supplies impurity standards to the United States Pharmacopeial Convention (USP).